J&J subsidiary gets FDA nod for obesity device

09/29/2007 | Forbes

The FDA has given Johnson & Johnson's Ethicon Endo-Surgery approval to market its Realize Band surgical implant device, designed to limit the food intake of patients with morbid obesity, the company said. The device moderates the digestion process while making patients feel full faster and longer.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR